GTC Biotherapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
175 Crossing Blvd Ste 410, Framingham, M...Phone Number
(508) 620-9700Website
www.gtc-bio.comRevenue
$18.4 MillionIndustry
About GTC Biotherapeutics
GTC Biotherapeutics Org Chart
Is GTC Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
GTC Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if GTC Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when GTC Biotherapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at GTC Biotherapeutics
Earning: See what the market has to say on GTC Biotherapeutics recently announced quarterly report
Click to see if GTC Biotherapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once GTC Biotherapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if GTC Biotherapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined GTC Biotherapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
GTC Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GTC Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GTC Biotherapeutics.
GTC Biotherapeutics Tech Stack
A closer look at the technologies used by GTC Biotherapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GTC Biotherapeutics
GTC Biotherapeutics develops, supplies, and commercializes therapeutic proteins produced through transgenic animal technology. In addition to ATryn®, GTC is developing a portfolio of recombinant human plasma proteins with known therapeutic properties. These proteins include recombinant forms of human coagulation factors VIIa and IX, which are used... Read More